VT-1161

DRUG4 trials

Sponsors

Viamet

Conditions

Candidiasis, VulvovaginalOnychomycosisRecurrent Vulvovaginal CandidiasisTinea Pedis

Phase 2

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)

CompletedNCT01891331

ViametCandidiasis, Vulvovaginal

Start: 2013-08-31End: 2014-12-31Updated: 2018-08-01

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

CompletedNCT01891305

ViametTinea Pedis

Start: 2013-08-31End: 2014-12-31Updated: 2018-08-01

A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

CompletedNCT02267382

ViametRecurrent Vulvovaginal Candidiasis

Start: 2015-02-10End: 2016-11-09Updated: 2019-10-15

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail

CompletedNCT02267356

ViametOnychomycosis

Start: 2015-02-17End: 2017-07-07Updated: 2020-11-04

Related Papers

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

Clinical Infectious Diseases2020-08-1356 citations

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.

2020-07-1326 citations